According to the most recent financial data from April 2026, the EPS for the trailing twelve months is $1.19. Cooper Companies's EPS for 2025 amounted to $1.88, marking a drop from $1.97 in 2024. During the quarterly period ending on Apr 30, 2026, COO's EPS stood at -$0.4.
Cooper Companies had an annual EPS of $1.88, indicating a drop of 4.6% from $1.97 in 2024. The quarterly per-share earnings for the period ending Apr 30, 2026, was -$0.4, indicating a 190.9% decrease from the same quarter last year. COO's 12-month EPS stands at $1.19 as of April 2026. Cooper Companies's annual EPS in 2024 stood at $1.97, a 32.2% increase year-over-year.
During the last 12 months, Cooper Companies has seen an EPS growth of -190.9% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -1.2% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 9.2%. A 10-year view shows that COO has seen an average EPS growth of 6% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| UTMD Utah Medical Products Inc | 20.01 | -12.1% | -8.4% | 3.4% |
| BSX Boston Scientific Corp | 20.15 | 55.6% | 63.3% | N/A |
| NVS Novartis AG | 21.25 | 21.8% | 31.2% | 15.2% |
| JNJ Johnson & Johnson | 26.66 | 90.6% | 17.7% | 14.8% |
| COO Cooper Companies Inc | 56.59 | -4.6% | -1.2% | 9.2% |
| TFX Teleflex Inc | N/A | -1,462.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.